Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c988 |
|---|---|
| Identifier | NCT05785715 |
| Trial Title | Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: NX-13 250mg|DRUG: NX-13 750mg|DRUG: NX-13 Placebo |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Miami |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2023-04-24 |
|---|---|
| Primary Completion Date | 2025-12-31 |
| Completion Date | 2025-12-31 |